Bafna Pharmaceuticals Limited (BOM:532989)

Market Cap	2.03B
Revenue (ttm)	1.46B
Net Income (ttm)	41.54M
Shares Out	n/a
EPS (ttm)	1.76
PE Ratio	48.77
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	791
Average Volume	1,208
Open	87.99
Previous Close	87.99
Day's Range	84.70 - 88.00
52-Week Range	67.80 - 94.90
Beta	n/a
RSI	48.06
Earnings Date	Aug 8, 2025

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, and internationally. The company was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited operates as a subsidiary of SRJR Lifesciences LLP.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 363
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532989

Financial Performance

In 2024, Bafna Pharmaceuticals's revenue was 1.46 billion, a decrease of -4.33% compared to the previous year's 1.52 billion. Earnings were 41.54 million, a decrease of -43.47%.